Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9X88
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $29,300
Award facts
- Contract value 100% obligated
- $29,300.21 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $29.3K delivery order to AmerisourceBergen Drug Corp on January 15, 2026, for the supply of Dupixent 300 mg/2 mL pen auto-injectors. This non-set-aside, firm fixed-price delivery order is scheduled for completion by January 16, 2026, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a task order under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999, which serves as a comprehensive global pharmaceutical support vehicle enabling delivery of prescription medications, specialty drugs, vaccines, and medical supplies to military healthcare systems and other federal medical institutions worldwide.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving as a critical federal vendor for military and veteran healthcare procurement. The company competed on a full and open basis for this award, demonstrating its capability to meet federal pharmaceutical supply requirements. Dupixent (dupilumab) is a biologic medication used to treat moderate-to-severe eczema and other inflammatory conditions, and this delivery order fulfills immediate medical supply needs within the Defense Health Agency's pharmaceutical distribution network supporting military treatment facilities and other federal health systems.
Quick answers
Who was awarded contract SPE2DR26F9X88?
SPE2DR26F9X88 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 15, 2026.
How much is contract SPE2DR26F9X88 worth?
The government has obligated $29,300 on SPE2DR26F9X88.
Is contract SPE2DR26F9X88 an order under another contract?
Yes. SPE2DR26F9X88 is a delivery order under SPE2DR25D3103, an indefinite delivery contract.
Was contract SPE2DR26F9X88 competed?
The extent of competition for SPE2DR26F9X88 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award